Life Care News

A Hope Of True Information

Copyright © 2015 - 2022 Lifecarenews.in

LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283

Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis

By Globe News Wire On Nov 12, 2022

Dupixent^® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis

Approval CHMP dupilumab Dupixent nodularis

Get real time updates directly on you device, subscribe now.

Globe News Wire

Prev Post

PRSA Names 2023 Board of Directors Following Election by Leadership Assembly Delegates

Next Post

Best Tempur-Pedic Mattress Black Friday Deals (2022): Top Early Tempur-Adapt, Tempur-Cloud & Tempur-Breeze Mattress Sales Reviewed by Spending Lab